InSite Vision
InSite Vision develops therapeutic products for common eye problems: infection, pain and inflammation in ocular surgery and glaucoma.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD74m (Public information from Sep 2015)
Alameda California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $22.2m | Growth Equity VC | |
N/A | $2.4m | Debt | |
$48.0m Valuation: $48.0m | Acquisition | ||
Total Funding | AUD34.3m |
Recent News about InSite Vision
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.